R&D | December 05, 2025
Industry-academia partnership key to advancing R&D agenda, says Dr. Jitendra Singh
Growing patent filings and tier-2 innovators reflect expanding national research base
Growing patent filings and tier-2 innovators reflect expanding national research base
The discussion at the fourth session was centered on the fusion of academic rigor and industrial pragmatism as a key to pioneering solutions for sustainable and prosperous future
The next phase of growth in pharma depends on the industry-oriented workforce, risk investment, academic revamp, and creation of R&D hubs, say experts .
The new MimixTM GeniTM reference standards were developed from the extensively tested Genome-in-a-Bottle Consortium (GIAB) cell line
This integrated center combines development, testing, evaluation, and industry-academia-research collaboration
This is the first industry-academia collaboration in the country, initiated through the CSR route, for advancing research in the areas of immuno-therapeutics and regenerative medicines
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
With milestone-linked funding of Rs. 5–25 crore per project (and up to Rs. 50 crore in exceptional cases), the Mission will support projects that bring impactful MedTech solutions to market
The acquisition centers on ImCheck’s lead Phase I/II program, ICT01, a first-in-class monoclonal antibody targeting BTN3A
Subscribe To Our Newsletter & Stay Updated
